ClinConnect ClinConnect Logo
Search / Trial NCT06068036

Telehealth Intervention Involving HEARTS Technical Package and Activity Monitor to Promote Physical Activity Post-stroke

Launched by FEDERAL UNIVERSITY OF MINAS GERAIS · Oct 3, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Stroke Physical Activity Telehealth Feasibility Study Randomized Controlled Trial

ClinConnect Summary

This clinical trial is looking at a new way to help people who have had a stroke become more active again. The study will test a program that combines support through phone calls and in-person meetings, along with the use of a smartwatch to track daily activity. The goal is to see if this approach can help increase physical activity levels after a stroke and to gather information that will help plan future studies.

To participate, you need to be at least 18 years old and have had a stroke for more than six months. You should also be considered "inactive," meaning you don’t currently get much exercise and have medical approval to start being more active. During the 12-week program, you'll be randomly assigned to either the group that gets the smartwatch or a comparison group that doesn't. Throughout the study, a trained researcher will collect information to see how well the program works and whether it can be used in larger studies in the future. If you are interested or think you might qualify, this could be a great opportunity to improve your health post-stroke!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of stroke for more than six months;
  • ≥18 years of age;
  • Be rated as "Inactive" according to Human Activity Profile (HAP);
  • Provide medical approval to practice physical activity.
  • Exclusion Criteria:
  • Positive screening test for possible cognitive alterations;
  • Pain or other adverse health condition that compromises the performance of the proposed intervention program, such as vestibular disorders, severe arthritis or any other diagnosis of disease of the nervous system.

About Federal University Of Minas Gerais

The Federal University of Minas Gerais (UFMG) is a prestigious academic institution in Brazil, renowned for its commitment to advancing research and education in the health sciences. With a strong emphasis on innovation and collaboration, UFMG conducts clinical trials that aim to improve patient outcomes and enhance medical knowledge. The university is equipped with cutting-edge facilities and a diverse team of experts dedicated to ethical research practices, contributing significantly to the global scientific community. Through its clinical trial initiatives, UFMG strives to address pressing health challenges and promote evidence-based solutions for better healthcare delivery.

Locations

Belo Horizonte, Minas Gerais, Brazil

Patients applied

0 patients applied

Trial Officials

Christina Faria, PhD

Principal Investigator

Federal University of Minas Gerais

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported